Catherine Berry

972 citations
26 papers · 598 · 2 hit papers · h-index 9

Impact in

    • Tuberculosis Research and Epidemiology
    • Pneumocystis jirovecii pneumonia detection and treatment
    • Mycobacterium research and diagnosis
    • Pneumonia and Respiratory Infections

Papers in

    • Tuberculosis Research and Epidemiology 20
    • Pneumocystis jirovecii pneumonia detection and treatment 3
    • Pneumonia and Respiratory Infections 2
    • Fungal Infections and Studies 1

Catherine Berry

25 papers receiving 573 citations

Catherine Berry's Hit Papers

Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis 2025 · 39 citations
390+1+2Years since publication50100150200

Peers

Catherine Berry
Comparison fields: 5 of 57
  • Infectious Diseases 427
  • Epidemiology 163
  • Molecular Medicine 23
  • Surgery 93
  • Applied Microbiology and Biotechnology 4
Replace Hye-Ryoun Kim with:
Hye-Ryoun Kim South Korea
Pablo González Montaner Argentina
Elena Martínez-Robles Spain
Bern-Thomas Nyang’wa United Kingdom
Franziska Ihle Germany
Hannetjie Ferreira South Africa
Jin Gu China
Saulius Diktanas Lithuania
Almari Conradie United States
Irina Y. Gelmanova United States
Catherine Berry relative to Hye-Ryoun Kim South Korea Hye-Ryoun Kim's profile →
Citations per field
00.5×5×10×14×
Hye-Ryoun Kim · 1×
Citations per year

Countries citing papers authored by Catherine Berry

Since Specialization
Citations

This map shows the geographic impact of Catherine Berry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Berry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Berry more than expected).

Fields of papers citing papers by Catherine Berry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Berry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Berry. The network helps show where Catherine Berry may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine Berry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine Berry Line = papers co-authored together Catherine Berry links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.

#Work
1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis
Hit paper breakdown →
2022241
2 202366
3
Oral Regimens for Rifampin-Resistant, Fluoroquinolone-Susceptible Tuberculosis
Hit paper breakdown →
202539
4 199838
5 202238
6 199833
7 202326
8 202223
9 202014
10 20139
11 20159
12 20219
13 20259
14 20198
15 20166
16 20236
17 20246
18 20165
19 20244
20 20253

About Catherine Berry

Catherine Berry is a scholar working on Infectious Diseases, Epidemiology, Pharmacology, Hematology and Economics and Econometrics, having authored 26 papers that have together received 598 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (20 papers), Pneumocystis jirovecii pneumonia detection and treatment (3 papers), Pneumonia and Respiratory Infections (2 papers), Drug-Induced Hepatotoxicity and Protection (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), Acute Myeloid Leukemia Research (1 paper), Fungal Infections and Studies (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Infectious Diseases (427 citations), Epidemiology (163 citations), Molecular Medicine (23 citations), Surgery (93 citations) and Applied Microbiology and Biotechnology (4 citations). Catherine Berry has collaborated with scholars based in United Kingdom, Netherlands and Australia. Frequent co-authors include Bern-Thomas Nyang’wa, Ilaria Motta, Katherine Fielding, Philipp du Cros, Emil Kazounis, Matthew Dodd, David Moore, Timothy Daniel McHugh, Nargiza Parpieva and Zinaida N. Tigay. Their work appears in journals such as European Respiratory Journal, Clinical Infectious Diseases, New England Journal of Medicine, The Lancet Respiratory Medicine and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact